• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在复合时间权衡中校正折扣和损失厌恶。

Correcting for discounting and loss aversion in composite time trade-off.

机构信息

Erasmus Centre for Health Economics Rotterdam, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, Netherlands.

Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, Netherlands.

出版信息

Health Econ. 2022 Aug;31(8):1633-1648. doi: 10.1002/hec.4529. Epub 2022 Apr 26.

DOI:10.1002/hec.4529
PMID:35474364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9541376/
Abstract

Time trade-off utilities have been suggested to be biased upwards. This bias is a result of the method being applied assuming linear utility of life duration, which is violated when individuals discount future life years or are loss averse for health. Applying a "corrective approach", that is, measuring individuals' discount function and loss aversion and correcting time trade-off utilities for these individual characteristics, may reduce this bias in utilities. Earlier work has developed this approach for time trade-off in a student sample. In this study, the corrective approach was extended to composite time trade-off (cTTO) methodology, which enabled correcting utilities for health states worse than dead. In digital interviews a sample of 150 members of the general public completed cTTO tasks for six health states, and afterward they completed measurements of loss aversion and discounting. cTTO utilities were corrected using these measurements under multiple specifications. Respondents were also asked to reflect on and adjust their cTTO utilities directly. Our results show considerable loss aversion and both positive and negative discounting were prevalent. As predicted, correction generally resulted in lower utilities. This was in accordance with the direction of adjustments made by respondents themselves.

摘要

时间权衡效用被认为存在向上偏差。这种偏差是由于该方法假设生命持续时间的线性效用,而当个体对未来生命年限进行贴现或对健康产生损失厌恶时,这种假设就会被违反。应用“修正方法”,即测量个体的贴现函数和损失厌恶程度,并对这些个体特征进行时间权衡效用修正,可以减少效用中的这种偏差。早期的工作已经为学生样本中的时间权衡开发了这种方法。在这项研究中,修正方法被扩展到复合时间权衡 (cTTO) 方法,该方法可以为比死亡状态更差的健康状态修正效用。在数字访谈中,一个由 150 名普通公众组成的样本完成了六个健康状态的 cTTO 任务,之后他们完成了损失厌恶和贴现的测量。根据多种规范,使用这些测量值对 cTTO 效用进行了修正。受访者还被要求直接反思和调整他们的 cTTO 效用。我们的结果显示出相当大的损失厌恶,并且普遍存在正向和负向贴现。正如预期的那样,修正通常会导致较低的效用。这与受访者自己所做的调整方向一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/622e/9541376/249bd3e9ccb8/HEC-31-1633-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/622e/9541376/249bd3e9ccb8/HEC-31-1633-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/622e/9541376/249bd3e9ccb8/HEC-31-1633-g001.jpg

相似文献

1
Correcting for discounting and loss aversion in composite time trade-off.在复合时间权衡中校正折扣和损失厌恶。
Health Econ. 2022 Aug;31(8):1633-1648. doi: 10.1002/hec.4529. Epub 2022 Apr 26.
2
Modifying the Composite Time Trade-Off Method to Improve Its Discriminatory Power.修改复合时间权衡法以提高其判别能力。
Value Health. 2023 Feb;26(2):280-291. doi: 10.1016/j.jval.2022.08.011. Epub 2022 Oct 14.
3
The effect of duration and time preference on the gap between adult and child health state valuations in time trade-off.时间偏好和持续时间对时间权衡中成人和儿童健康状态估值差距的影响。
Eur J Health Econ. 2024 Jun;25(4):601-613. doi: 10.1007/s10198-023-01612-8. Epub 2023 Jul 8.
4
Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology.时间权衡法评估 EQ-5D-Y 时的时间和词典偏好。
Eur J Health Econ. 2023 Mar;24(2):293-305. doi: 10.1007/s10198-022-01466-6. Epub 2022 May 21.
5
A threshold explanation for the lack of variation in negative composite time trade-off values.负面复合时间权衡值缺乏变化的阈解释。
Qual Life Res. 2022 Sep;31(9):2753-2761. doi: 10.1007/s11136-022-03155-6. Epub 2022 May 27.
6
Re-revisiting the Utilities of Health States Worse than Dead: The Problem Remains.重新审视劣于死亡健康状态的效用:问题依然存在。
Med Decis Making. 2023 Oct-Nov;43(7-8):875-885. doi: 10.1177/0272989X231201147. Epub 2023 Oct 16.
7
Deriving time discounting correction factors for TTO tariffs.推导 TTO 关税的时间贴现修正系数。
Health Econ. 2014 Apr;23(4):410-25. doi: 10.1002/hec.2921. Epub 2013 Apr 7.
8
A Head-On Ordinal Comparison of the Composite Time Trade-Off and the Better-Than-Dead Method.综合时间权衡法和优于死亡法的直面序贯比较。
Value Health. 2020 Feb;23(2):236-241. doi: 10.1016/j.jval.2019.10.006. Epub 2019 Dec 16.
9
How different are composite and traditional TTO valuations of severe EQ-5D-5L states?对于严重的EQ-5D-5L状态,综合评估与传统的TTO评估有多大差异?
Qual Life Res. 2016 Aug;25(8):2101-8. doi: 10.1007/s11136-016-1242-5. Epub 2016 Feb 13.
10
A consistency test of the time trade-off.时间权衡的一致性测试。
J Health Econ. 2003 Nov;22(6):1037-52. doi: 10.1016/s0167-6296(03)00046-8.

引用本文的文献

1
Loss aversion in EQ-5D-Y-3L: does it explain differences in willingness to trade-off life years in adults and children?EQ-5D-Y-3L中的损失厌恶:它能解释成人和儿童在权衡生命年数意愿上的差异吗?
Eur J Health Econ. 2025 Apr 12. doi: 10.1007/s10198-025-01775-6.
2
Immediate Death: Not So Bad If You Discount the Future but Still Worse than It Should Be.猝死:如果你不考虑未来,倒也不算太糟,但仍比应有的情况更糟糕。
Med Decis Making. 2025 May;45(4):376-384. doi: 10.1177/0272989X251325828. Epub 2025 Mar 20.
3
Implications of Diminishing Lifespan Marginal Utility for Valuing Equity in Cost-Effectiveness Analysis.

本文引用的文献

1
Time for Tele-TTO? Lessons Learned From Digital Interviewer-Assisted Time Trade-Off Data Collection.电话时间贸易-off(Tele-TTO)的时机到了吗?从数字化访谈员辅助时间贸易-off 数据收集中学到的经验。
Patient. 2021 Sep;14(5):459-469. doi: 10.1007/s40271-020-00490-z. Epub 2020 Dec 21.
2
What is it going to be, TTO or SG? A direct test of the validity of health state valuation.这将是 TTO 还是 SG?对健康状态估值有效性的直接检验。
Health Econ. 2020 Nov;29(11):1475-1481. doi: 10.1002/hec.4131. Epub 2020 Aug 3.
3
The EQ-5D-5L Value Set for England: Findings of a Quality Assurance Program.
寿命边际效用递减对成本效益分析中公平性评估的影响
MDM Policy Pract. 2025 Jan 17;10(1):23814683241305106. doi: 10.1177/23814683241305106. eCollection 2025 Jan-Jun.
4
Scale and rate heterogeneity in the EQ-5D-5L valuation.EQ-5D-5L 量表值的标度和率异质性。
Health Qual Life Outcomes. 2024 Jul 13;22(1):55. doi: 10.1186/s12955-024-02271-w.
5
Comparing heuristic valuation processes between health state valuation from child and adult perspectives.比较儿童和成人健康状态估值的启发式估值过程。
Eur J Health Econ. 2024 Nov;25(8):1345-1360. doi: 10.1007/s10198-023-01668-6. Epub 2024 Feb 3.
6
The effect of duration and time preference on the gap between adult and child health state valuations in time trade-off.时间偏好和持续时间对时间权衡中成人和儿童健康状态估值差距的影响。
Eur J Health Econ. 2024 Jun;25(4):601-613. doi: 10.1007/s10198-023-01612-8. Epub 2023 Jul 8.
7
Correction to: Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology.对《采用时间权衡法评估EQ-5D-Y时的时间和词典排序偏好》的更正
Eur J Health Econ. 2022 Dec;23(9):1613-1615. doi: 10.1007/s10198-022-01530-1. Epub 2022 Oct 5.
英国 EQ-5D-5L 价值集:质量保证计划的调查结果。
Value Health. 2020 May;23(5):642-648. doi: 10.1016/j.jval.2019.10.017. Epub 2020 Mar 13.
4
International Valuation Protocol for the EQ-5D-Y-3L.国际 EQ-5D-Y-3L 量表评估协议
Pharmacoeconomics. 2020 Jul;38(7):653-663. doi: 10.1007/s40273-020-00909-3.
5
Living up to expectations: Experimental tests of subjective life expectancy as reference point in time trade-off and standard gamble.不负众望:主观预期寿命作为时间权衡和标准博弈参考点的实验检验。
J Health Econ. 2020 May;71:102318. doi: 10.1016/j.jhealeco.2020.102318. Epub 2020 Mar 27.
6
Good things come to those who wait-Decreasing impatience for health gains and losses.好事多磨——减少对健康得失的急躁。
PLoS One. 2020 Mar 3;15(3):e0229784. doi: 10.1371/journal.pone.0229784. eCollection 2020.
7
The Corrective Approach: Policy Implications of Recent Developments in QALY Measurement Based on Prospect Theory.矫正方法:基于前景理论的 QALY 测量新进展对政策的启示。
Value Health. 2019 Jul;22(7):816-821. doi: 10.1016/j.jval.2019.01.013. Epub 2019 May 17.
8
QALYs without bias? Nonparametric correction of time trade-off and standard gamble weights based on prospect theory.基于前景理论的时间权衡和标准博弈权重的无偏 QALYs 非参数校正。
Health Econ. 2019 Jul;28(7):843-854. doi: 10.1002/hec.3895.
9
Severity-Adjusted Probability of Being Cost Effective.调整严重程度后的成本效益概率。
Pharmacoeconomics. 2019 Sep;37(9):1155-1163. doi: 10.1007/s40273-019-00810-8.
10
Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol.概述、更新以及从国际 EQ-5D-5L 估值工作中吸取的经验教训:EQ-5D-5L 估值议定书第 2 版。
Value Health. 2019 Jan;22(1):23-30. doi: 10.1016/j.jval.2018.05.010. Epub 2019 Jan 2.